http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2389486-C1
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_830546519f5f26ac1c4c6d577378e060 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-198 |
filingDate | 2008-12-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2010-05-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a3b127789f86867bb922b0ac66dbc485 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_789ccc9a05d4c7e0765b5fbcf5f4516a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_963f29d9e1762da42ac6331a1efab15f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1d267b57fe21393a35a931e71bdb44d5 |
publicationDate | 2010-05-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | RU-2389486-C1 |
titleOfInvention | Inhibitor of exertional cytoskeletal proteolysis of skeletal muscles |
abstract | FIELD: medicine. n SUBSTANCE: there is offered application of L-arginine as an inhibitor of eccentric exertional cytoskeletal proteolysis skeletal muscles. The invention can find application in sports medicine, aerospace medicine and sports physiology. n EFFECT: almost complete prevention of cytoskeletal protein degradation in skeletal muscles, and elimination of adverse by-effects of the applied prophylactic agent. n 4 dwg |
priorityDate | 2008-12-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 308.